DÄ internationalArchive8/2011Target Range Was Missed

Correspondence

Target Range Was Missed

Dtsch Arztebl Int 2011; 108(8): 134. DOI: 10.3238/arztebl.2011.0134a

Nauck, M; Wallaschofski, H; Hannemann, D D A

LNSLNS

As an addendum to the article, which details the use of hormone replacement therapy after thyroid surgery, we wish to emphasize the importance of continuous therapeutic monitoring. As a target range for L-thyroxine substitution, a TSH serum concentration of 1–2 mU/L was recommended. Studies from the US (1) and the UK (2) give rise to the suspicion that a substantial proportion of patients receiving drug treatment for thyroid disorders are not adequately monitored in terms of their metabolic function. The results of one of our own studies from Germany (3), based on data from the population-based Study of Health in Pomerania (SHIP) showed that of 266 participants who took thyroid medication, 31% had TSH serum concentrations outside the local, study specific reference range and therefore missed the target range mentioned above.

In addition to unsatisfactory patient compliance, inappropriate dosage adjustment will result in mistreatment of thyroid disorders, which may be accompanied by adverse effects and constitutes a crucial reason for poor therapeutic results. We therefore recommend establishing therapeutic target ranges and placing more importance on monitoring drug treatment.

DOI: 10.3238/arztebl.2011.0134a

Prof. Dr. med. Matthias Nauck

Prof. Dr. med. Henri Wallaschofski

Dipl. Demogr. Anke Hannemann

Institut für Klinische Chemie und Laboratoriumsmedizin

Ernst-Moritz-Arndt Universität Greifswald

Ferdinand-Sauerbruch-Str.

17475 Greifswald, Germany

anke.hannemann@uni-greifswald.de

1.
Hollowell JG, et al.: Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87(2): 489–99. MEDLINE
2.
De Whalley P: Do abnormal thyroid stimulating hormone level values result in treatment changes? A study of patients on thyroxine in one general practice. Br J Gen Pract 1995; 45(391): 93–5. MEDLINE
3.
Hannemann A, et al.: Thyroid function tests in patients taking thyroid medication in Germany: Results from the population-based Study of Health in Pomerania (SHIP). BMC Res Notes. 3: p. 227.
4.
Schäffler A: Hormone replacement after thyroid and parathyroid surgery. Dtsch Arztebl Int 2010; 107(47): 827–34. VOLLTEXT
1.Hollowell JG, et al.: Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87(2): 489–99. MEDLINE
2.De Whalley P: Do abnormal thyroid stimulating hormone level values result in treatment changes? A study of patients on thyroxine in one general practice. Br J Gen Pract 1995; 45(391): 93–5. MEDLINE
3.Hannemann A, et al.: Thyroid function tests in patients taking thyroid medication in Germany: Results from the population-based Study of Health in Pomerania (SHIP). BMC Res Notes. 3: p. 227.
4.Schäffler A: Hormone replacement after thyroid and parathyroid surgery. Dtsch Arztebl Int 2010; 107(47): 827–34. VOLLTEXT